ByTrending Posts
How Eli Lilly-Backed Persist AI Secured $12M to…
Key highlights Persist AI, a healthcare deep tech startup based in Sacramento, CA, has successfully raised $12 million…
How Is WorkDoneAI Transforming Healthcare Documentation Compliance with…
Key Highlights of WorkDone’s $1.8M Seed Funding: San Francisco, CA – WorkDone, a Y Combinator-backed healthcare AI startup,…
How Is TrialMatchAI from Bordeaux Bioinformatics Center Revolutionizing…
Key Highlights: The Bordeaux Bioinformatics Center, in collaboration with the EOSC4Cancer initiative, has unveiled TrialMatchAI, an advanced AI-driven…
How Can AI Transform Cancer Treatment? KOLs Insights…
Baltimore, MD — With the rapid advancement of artificial intelligence (AI), predictive medicine is becoming a pivotal part…
How Heidi Health’s $16.6M Raise Is Empowering Clinicians…
Heidi Health Secures $16.6M to Revolutionize Clinical Workflows with AI-Powered Scribe Melbourne, Australia – March 3, 2025 –…
Can Hinge Health’s $100 Million IPO Redefine AI-Powered…
San Francisco, CA – 25 May 2025 Key Highlights > IPO Launch: Hinge Health targets $100 million raise…
AI Meets Genomics: Predictive Oncology’s PEDAL™ Platform Advances…
Breakthrough aligns with Regeneron’s genomics strategy, signaling acceleration in precision oncology development PITTSBURGH, May 22, 2025 – Predictive…
How Qubit Pharmaceuticals’ Quantum AI Model FeNNix-Bio1 is…
May 23, 2025 Advancing Molecular Simulation for Faster Drug Development Qubit Pharmaceuticals, in collaboration with Sorbonne University, has…
Can AI-Powered Screening Revolutionize Cancer Detection in India?…
May 23, 2025 A Nationwide Step Toward Preventive Cancer Care Metropolis Healthcare Limited has introduced TruHealth Cancer Screen…
Trending Posts
Latest Stories
Neuroscience Biopharma in Transformation: Pipeline and Commercial Dynamics Reshape the Industry
Washington, D.C. — The neuroscience segment is undergoing a significant strategic transformation, driven by breakthroughs…
How Will New U.S. Drug Pricing Policies Reshape the Pharmaceutical Ecosystem?
Washington, D.C. — December 29, 2025 — Recent changes in U.S. drug pricing policies are…
How Did Merck’s 2025 Deals Strengthen Its Pipeline and What Could They Mean for Future Growth?
In 2025, Merck pursued a series of high-impact collaborations, acquisitions, and licensing agreements to expand…
Did Merck’s 2025 Strategies, Deals, and Pipeline Strength Position It for Breakthrough Growth in 2026?
Merck concluded 2025 with a strong performance across its pharmaceuticals, vaccines, and oncology segments, demonstrating…
Gallery
